Healthcare Stocks Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol Therapeutics Inc. (NASDAQ:… Ryan AllwaySeptember 24, 2024
Feature Healthcare Stocks Top News Positive Phase 2 Results Signal Promising Future For Cardiol Therapeutics The future of smaller drug development companies frequently hinges on the results… Robin LeffertsJune 20, 2024
Feature Healthcare Stocks Top News Near-Term Catalysts on the Horizon for Cardiol Therapeutics Investing in smaller drug development companies requires patience. The journey from discovery… Robin LeffertsMay 28, 2024
Feature Healthcare Stocks Top News Analyst and Research Coverage Bullish on Cardiol Therapeutics Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) has in some ways burst… Robin LeffertsMay 1, 2024
Feature Healthcare Stocks Top News The Impact of Orphan Drug Development on a Smaller Company Orphan drugs treat conditions with less than 200,000 patients annually in the… Robin LeffertsFebruary 6, 2024
Feature Healthcare Stocks Top News Is Reducing Fat the Key to Treating Heart Failure? Everybody knows that excessive fat can lead to a wide variety of… Robin LeffertsOctober 18, 2023
